Search

Champions Oncology Inc

Open

BrancheGesundheitswesen

5.37 0.19

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.26

Max

5.55

Schlüsselkennzahlen

By Trading Economics

Einkommen

-389K

-667K

Verkäufe

1.5M

17M

KGV

Branchendurchschnitt

35.118

64.641

EPS

-0.05

Gewinnspanne

-4.028

Angestellte

213

EBITDA

-626K

-522K

Dividenden

By Acuity

Nächstes Ergebnis

11. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-555K

84M

Vorheriger Eröffnungskurs

5.18

Vorheriger Schlusskurs

5.37

Nachrichtenstimmung

By Acuity

15%

85%

25 / 340 Ranking in Healthcare

Champions Oncology Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Aug. 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

31. Juli 2026, 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

30. Juli 2026, 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

29. Juli 2026, 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

28. Juli 2026, 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

27. Juli 2026, 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

24. Juli 2026, 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22. Juli 2026, 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Peer-Vergleich

Kursveränderung

Champions Oncology Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Stimmung

By Acuity

25 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat